Proposal to list medical devices supplied by Teleflex Medical New Zealand
PHARMAC is seeking feedback on a proposal to list a range of respiratory products and a range of endomechanical and electrosurgical products in Part III of Section H of the Pharmaceutical Schedule from 1 October 2019 through provisional agreements with Teleflex Medical New Zealand.
Closes: 4pm on Wednesday, 21 August 2019.
Proposal for funding of oncology, multiple sclerosis and respiratory treatments
We are seeking feedback on a proposal to fund three new treatments and widen access to one currently funded treatment through a provisional agreement with Roche Products (NZ) Limited (Roche).
Closes: 5pm Wednesday, 21 August 2019.
Proposals for funding in the immunosuppressant, cardiovascular and antinausea therapeutic areas
We are seeking feedback on proposals for widening access to medicines in the immunosuppressant, cardiovascular and antinausea therapeutic areas.
Closes: 5pm Friday, 23 August 2019.
2019/20 invitation to tender (medical)
PHARMAC is seeking feedback from medical groups, DHB hospital pharmacies and other interested parties on:
- A proposal to tender certain pharmaceuticals for sole supply; and
- The draft process and terms and conditions for the 2019/20 Invitation to Tender (2019/20 Tender).
PHARMAC welcomes all feedback on the 2018/19 Tender.
All responses are due by 5pm, Friday 30 August 2019
2019/20 invitation to tender (suppliers)
PHARMAC is seeking feedback from pharmaceutical suppliers and interested parties on:
- A proposal to tender certain pharmaceuticals for sole supply;
- The draft process and terms and conditions for the 2019/20 Invitation to Tender (2019/20 Tender); and
- Commercial proposals as an alternative to tendering.
PHARMAC welcomes all feedback on the draft 2019/20 Tender.
Alternative commercial proposal responses due by
5 pm, Monday 26 August 2019
All other consultation responses due by
5 pm, Friday 30 August 2019
Decision to change funded male latex condoms
We’re pleased to announce changes to funded male latex condoms that will result in a wider range of funded male latex condoms becoming available, including flavoured condoms in a range of sizes and thin and coloured condoms becoming funded for the first time.
July 2019 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2016/17 Invitation to Tender dated 3 November 2016, 2017/18 Invitation to Tender dated 2 November 2017, and the 2018/19 Invitation to Tender dated 1 November 2018.
Changes to funded vaccines in the National Immunisation Schedule
What we are doing We’re pleased to announce decisions related to the National Immunisation Schedule that will take effect from 1 July 2020. The decisions have been...
Decision to list medical devices supplied by ResMed NZ Limited
We are pleased to announce the approval of a non-exclusive listing agreement with ResMed NZ Limited for the supply of non-invasive ventilation equipment and associated consumables.
RFP - supply of fluticasone, and fluticasone with salmeterol, metered dose inhalers
PHARMAC invites proposals for the supply of fluticasone, and fluticasone with salmeterol, metered dose inhalers in New Zealand.
All proposals must be submitted to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 5pm NZT Monday 19 August 2019 - RFx ID 21314358.
If you have any questions about this RFP, please post these on the Government Electronic Tenders Service (www.gets.govt.nz).
Answers to questions will be provided through the Government Electronic Tenders Service (GETS). PHARMAC will also post any addenda through GETS. We encourage interested organisations to register with GETS and subscribe to this RFP to be kept up to date.
Proposal to list urology, ostomy and continence products supplied by Jackson Allison Medical & Surgical Limited
PHARMAC is seeking feedback on a proposal to list a range of urology, ostomy and continence, products in Part III of Section H of the Pharmaceutical Schedule from 1 October 2019, through a listing agreement with Jackson Allison Medical & Surgical Limited).
Consultation closes at 4pm on Thursday, 15 August 2019.
Decision to decline inactive medicines funding applications
To give people more clarity about what medicines we are, or are not, actively considering for funding, we will be making more decisions on inactive applications.
OIA Response: Medical cannabis meetings
Request dated 12 June 2019 under the Official Information Act 1982 (OIA) for information relating to meetings about medical cannabis.
OIA Response: Pfizer PHARMAC communications
Request dated 5 June 2019 under the Official Information Act 1982 (OIA) for information relating to communications between PHARMAC and Pfizer.
OIA Response: University of Auckland communications
Request dated 7 June 2019 under the Official Information Act 1982 (OIA) for information relating to various communications between PHARMAC and third parties.
Proposal to change access to amino acid infant formula
We are proposing to make changes to the access criteria for funding of amino acid infant formula (AAF) from 1 July 2020. AAF (brand names Alfamino Junior, Elecare and Neocate) is used as a milk substitute in infants who have an allergy or severe intolerance to cow’s milk and cannot take other funded milk substitutes.
Closes: 5pm Tuesday, 13 August 2019.
RFP - supply of rituximab
PHARMAC invites proposals for the supply of rituximab in New Zealand.
All proposals must be submitted to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz) no later than 5pm NZT Monday 12 August 2019 - RFx ID 21271575.
If you have any questions about this RFP, please post these on the Government Electronic Tenders Service (www.gets.govt.nz).
Answers to questions will be provided through the Government Electronic Tenders Service (GETS). PHARMAC will also post any addenda through GETS. We encourage interested organisations to register with GETS and subscribe to this RFP to be kept up to date.
Proposal to list medical devices supplied by Downs Distributors Limited
PHARMAC is seeking feedback on a proposal to list a range of obstetrics and gynaecology products and endomechanical and electrosurgical products in Part III of Section H of the Pharmaceutical Schedule from 1 September 2019 through a provisional agreement with Downs Distributors Limited.
Closes: 4pm Friday, 2 August 2019.
Decision to list medical devices supplied by CR Kennedy (NZ) Limited
We are pleased to announce the approval of a non-exclusive listing agreement with CR Kennedy (NZ) Limited for the supply of urology products to DHBs.
Decision to list medical devices in the endomechanical and electrosurgical category supplied by Device Technologies Australia Pty Ltd
We are pleased to announce the approval of a listing agreement for medical devices with Device Technologies Australia Pty Ltd for products in the endomechanical and electrosurgical category of medical devices.
Newsletters
Device Advice: Your update on PHARMAC’s Hospital Medical Devices programme.
Te Whaioranga ePānui: A PHARMAC newsletter for people with an interest in Māori health.
